---
title: "Trump's proposed 100% drug tariffs could have loopholes lessening impact on consumers, Big Pharma displeased. Asian markets rattled. U.S. investors affected, some companies see premarket shares rise."
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/259090215.md"
description: "President Trump's proposed 100% tariffs on pharmaceuticals may have less impact due to loopholes, despite Big Pharma's dissatisfaction. The tariffs stem from an investigation into medical products from China, Vietnam, and Malaysia. Analyst Louise Loo warns of significant effects on U.S. consumers. Asian markets have declined, while U.S. pharmaceutical companies like Pfizer, Eli Lilly, and Bristol-Myers Squibb have seen premarket share increases."
datetime: "2025-09-26T13:32:24.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/259090215.md)
  - [en](https://longbridge.com/en/news/259090215.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/259090215.md)
generator: "portal-rs"
---

# Trump's proposed 100% drug tariffs could have loopholes lessening impact on consumers, Big Pharma displeased. Asian markets rattled. U.S. investors affected, some companies see premarket shares rise.

President Donald Trump's plan to impose 100% tariffs on pharmaceuticals may have a smaller effect than originally anticipated due to certain loopholes, although the pharmaceutical industry, notably Big Pharma, remains dissatisfied. Trump's investigation under Section 232 to evaluate whether medical products from China, Vietnam, and Malaysia are a national security threat has resulted in the proposed tariffs. This is likely to impact U.S. consumers and exporters in these nations. Oxford Economics' analyst Louise Loo forecasts that the drug tariffs will significantly impact American consumers. The news has caused a downturn in Asian markets, though some U.S. pharmaceutical companies such as Pfizer, Eli Lilly, and Bristol-Myers Squibb have seen a boost in premarket shares.

### Related Stocks

- [BMY.US](https://longbridge.com/en/quote/BMY.US.md)
- [PFE.US](https://longbridge.com/en/quote/PFE.US.md)
- [LLY.US](https://longbridge.com/en/quote/LLY.US.md)

## Related News & Research

- [Bristol Myers' blood cancer cell therapy meets main goal in mid-stage trial](https://longbridge.com/en/news/298308696.md)
- [BMS reports positive data from Phase II QUINTESSENTIAL study for r/r MM](https://longbridge.com/en/news/298442546.md)
- [Bristol Myers Swoons on Test Results](https://longbridge.com/en/news/298335284.md)
- [Eli Lilly and Company $LLY Shares Purchased by Integrated Wealth Concepts LLC](https://longbridge.com/en/news/298698438.md)
- [Novartis, Bristol Myers pause autoimmune CAR-T trials due to safety concerns](https://longbridge.com/en/news/298117865.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**